β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  World Journal of Diabetes

• Publication date

  2015-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.4239/wjd.v6.i1.109PMID 25685282PMCID PMC4317303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Remission

  2015cited by this paper
• Body Composition Is the Main Determinant for the Difference in Type 2 Diabetes Pathophysiology Between Japanese and Caucasians

  2014cited by this paper
• Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes

  2014cited by this paper
• Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

  2014cited by this paper
• Intensive lifestyle intervention reduces urinary incontinence in overweight/obese men with type 2 diabetes: results from the Look AHEAD trial.

  2014cited by this paper
• Involvement of Oxidative Stress–Induced DNA Damage, Endoplasmic Reticulum Stress, and Autophagy Deficits in the Decline of β-Cell Mass in Japanese Type 2 Diabetic Patients

  2014cited by this paper
• Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial

  2014cited by this paper
• Obesity, Type 2 Diabetes and Beta Cell Failure: An Asian Perspective

  2014cited by this paper
• Importance of Beta Cell Function for the Treatment of Type 2 Diabetes

  2014cited by this paper
• Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies

  2014cited by this paper
• Islet Number Rather Than Islet Size Is a Major Determinant of (cid:2) - and (cid:3) -Cell Mass in Humans

  2014cited by this paper
• Inside the pancreas: progress and challenges of human beta cell mass quantification

  2014cited by this paper
• Limited Recovery of β-Cell Function After Gastric Bypass Despite Clinical Diabetes Remission

  2014cited by this paper
• Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.

  2014cited by this paper
• Insulin Resistance Alters Islet Morphology in Nondiabetic Humans

  2014cited by this paper
• Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.

  2014cited by this paper
• Healthy Behavior Change and Cardiovascular Outcomes in Newly Diagnosed Type 2 Diabetic Patients: A Cohort Analysis of the ADDITION-Cambridge Study

  2014cited by this paper
• Betatrophin Versus Bitter-Trophin and the Elephant in the Room: Time for a New Normal in β-Cell Regeneration Research

  2014cited by this paper
• Impact of Intensive Lifestyle Intervention on Depression and Health-Related Quality of Life in Type 2 Diabetes: The Look AHEAD Trial

  2014cited by this paper
• Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2 diabetes.

  2014cited by this paper
• Islet number rather than islet size is a major determinant of β- and α-cell mass in humans.

  2014cited by this paper
• Elevated Mouse Hepatic Betatrophin Expression Does Not Increase Human β-Cell Replication in the Transplant Setting

  2014cited by this paper
• Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.

  2014cited by this paper
• Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20).

  2014cited by this paper
• Predictors of remission of type 2 diabetes mellitus in obese patients after gastrointestinal surgery.

  2013cited by this paper
• Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2013cited by this paper
• Age‐associated changes of islet endocrine cells and the effects of body mass index in Japanese

  2013cited by this paper
• Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.

  2013cited by this paper
• HbA1c variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2

  2013cited by this paper
• Do lifestyle changes reduce serious outcomes in diabetes?

  2013cited by this paper
• Genetic Risk Score of 46 Type 2 Diabetes Risk Variants Associates With Changes in Plasma Glucose and Estimates of Pancreatic β-Cell Function Over 5 Years of Follow-Up

  2013cited by this paper
• Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials

  2013cited by this paper
• Factors associated with glycemic variability in Japanese patients with diabetes

  2013cited by this paper
• Diabetes-Free Survival in Patients Who Underwent Islet Autotransplantation After 50% to 60% Distal Partial Pancreatectomy for Benign Pancreatic Tumors

  2013cited by this paper
• Effects of Common Genetic Variants Associated With Type 2 Diabetes and Glycemic Traits on α- and β-Cell Function and Insulin Action in Humans

  2013cited by this paper
• Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY

  2013cited by this paper
• Effects of Mitiglinide, a Short-Acting Insulin Secretagogue, on Daily Glycemic Variability and Oxidative Stress Markers in Japanese Patients with Type 2 Diabetes Mellitus

  2013cited by this paper
• Pancreatic islet enhancer clusters enriched in type 2 diabetes risk–associated variants

  2013cited by this paper
• Ethnic Differences in the Relationship Between Insulin Sensitivity and Insulin Response

  2013cited by this paper
• Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes

  2013cited by this paper
• birth , and death

  2013cited by this paper
• The Clinical Efficacy and Safety of Sodium Glucose Cotransporter‐2 Inhibitors in Adults with Type 2 Diabetes Mellitus

  2013cited by this paper
• Trends in antidiabetic prescription patterns in Japan from 2005 to 2011.

  2013cited by this paper
• β-cell dedifferentiation in diabetes is important, but what is it?

  2013cited by this paper
• Association between beta cell function and future glycemic control in patients with type 2 diabetes.

  2013cited by this paper
• SGLT inhibitors in management of diabetes.

  2013cited by this paper
• The genetics of type 2 diabetes and its clinical relevance

  2013cited by this paper
• US regulators relax restrictions on rosiglitazone

  2013cited by this paper
• Are Metabolically Healthy Overweight and Obesity Benign Conditions?

  2013cited by this paper
• Role of Reduced β-Cell Mass Versus Impaired β-Cell Function in the Pathogenesis of Type 2 Diabetes

  2013cited by this paper
• Postprandial serum C-peptide to plasma glucose ratio predicts future insulin therapy in Japanese patients with type 2 diabetes

  2013cited by this paper
• AACE comprehensive diabetes management algorithm 2013.

  2013cited by this paper
• Predominance of β-cell neogenesis rather than replication in humans with an impaired glucose tolerance and newly diagnosed diabetes.

  2013cited by this paper
• Change in β-cell mass in Japanese nondiabetic obese individuals.

  2013cited by this paper
• β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?

  2013cited by this paper
• β-Cell Mass and Turnover in Humans

  2012cited by this paper
• Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis

  2012cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

  2012cited by this paper
• Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans

  2012cited by this paper
• Association of an intensive lifestyle intervention with remission of type 2 diabetes.

  2012cited by this paper
• Formation of a human β-cell population within pancreatic islets is set early in life.

  2012cited by this paper
• HbA1c variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2

  2012cited by this paper
• Effect of obesity on declining beta cell function after diagnosis of type 2 diabetes: a possible link suggested by cross-sectional analysis.

  2012cited by this paper
• Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study

  2012cited by this paper
• Predicting the Glycemic Response to Gastric Bypass Surgery in Patients With Type 2 Diabetes

  2012cited by this paper
• Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic review.

  2012cited by this paper
• Mitochondrial dysfunction in pancreatic β cells.

  2012cited by this paper
• Genetic Risk Score Constructed Using 14 Susceptibility Alleles for Type 2 Diabetes Is Associated With the Early Onset of Diabetes and May Predict the Future Requirement of Insulin Injections Among Japanese Individuals

  2012cited by this paper
• Adaptive changes of human islets to an obesogenic environment in the mouse

  2012cited by this paper
• Basal insulin and cardiovascular and other outcomes in dysglycemia.

  2012cited by this paper
• IMPACT OF OBESITY SEVERITY AND DURATION ON PANCREATIC β-AND α-CELLS DYNAMICS IN NORMOGLYCEMIC NON-HUMAN PRIMATES

  2012cited by this paper
• Pathophysiologic Differences Among Asians, Native Hawaiians, and Other Pacific Islanders and Treatment Implications

  2012cited by this paper
• Safety, tolerability, and efficacy of metformin extended-release oral antidiabetic therapy in patients with type 2 diabetes: An observational trial in Asia

  2012cited by this paper
• Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis

  2012cited by this paper
• Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.

  2012cited by this paper
• b-Cell Mass and Turnover in Humans Effects of obesity and aging

  2012cited by this paper
• Fasting Insulin Levels and Metabolic Risk Factors in Type 2 Diabetic Patients at the First Visit in Japan

  2012cited by this paper
• Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure.

  2012cited by this paper
• Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study

  2012cited by this paper
• HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study

  2012cited by this paper
• Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials

  2012cited by this paper
• Glycated albumin to glycated hemoglobin ratio reflects postprandial glucose excursion and relates to beta cell function in both type 1 and type 2 diabetes

  2011cited by this paper
• Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT

  2011cited by this paper
• Chronic Reduction of Fasting Glycemia With Insulin Glargine Improves First- and Second-Phase Insulin Secretion in Patients With Type 2 Diabetes

  2011cited by this paper
• Ongoing β-Cell Turnover in Adult Nonhuman Primates Is Not Adaptively Increased in Streptozotocin-Induced Diabetes

  2011cited by this paper
• Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies

  2011cited by this paper
• Rosiglitazone: a European regulatory perspective

  2011cited by this paper
• Effects of Exenatide on Measures of β-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes

  2011cited by this paper
• Beta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia: a randomised controlled trial

  2011cited by this paper
• Diabetes mellitus, fasting glucose, and risk of cause-specific death.

  2011cited by this paper
• Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone

  2011cited by this paper
• Weight loss, exercise, or both and physical function in obese older adults.

  2011cited by this paper
• Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes.

  2011cited by this paper
• Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

  2011cited by this paper
• Pioglitazone for diabetes prevention in impaired glucose tolerance.

  2011cited by this paper
• Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes

  2011cited by this paper
• Pancreatic alpha cell mass in European subjects with type 2 diabetes

  2011cited by this paper
• β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition.

  2011cited by this paper
• Antioxidant drugs for treating beta-cell oxidative stress in type 2 diabetes: glucose-centric versus insulin-centric therapy.

  2010cited by this paper
• Imaging of β-Cell Mass and Function

  2010cited by this paper

• Engineering the pancreatic niche: Mechanobiological insights into stem cell-derived β-cell therapy for diabetes mellitus

  2026cites this paper
• Transition from Continuous Subcutaneous Insulin Infusion to IDeg-Based Regimens in Hospitalized T2DM Patients: A Single-Center Retrospective Analysis

  2026cites this paper
• Genetic association of ABCA1 gene polymorphism (rs1800977 & rs2230806) and susceptibility to type 2 diabetes mellitus in South Indian cohort

  2026cites this paper
• Machine learning and engagement insights for personalized blood glucose management

  2026cites this paper
• In Vivo Models of Diabetes: Unravelling Molecular Pathways in Metabolic and Skeletal Complications

  2026cites this paper
• Harnessing Phytochemicals and Nanotechnology Synergy for Molecular, Epigenetic, and Microbiota-Driven Regulation in Type 2 Diabetes Mellitus

  2026cites this paper
• Enhancement of Glucose-Stimulated Insulin Secretion and Pancreatic β-Cell Functionality Through Microwave-Assisted Processing of Zingiber officinale Roscoe

  2026cites this paper
• Clinical Utility of the Novel Classification of Type 2 Diabetes (T2D) among Ghanaian Patients Diagnosed with T2D: Evidence from a Multicenter Hospital-based Study in Accra, Ghana

  2026cites this paper
• Long-term effectiveness on glycemic control of insulin compared to combined oral antidiabetic drugs for initial intensive treatment in newly diagnosed type 2 diabetes: A duplicated target trial

  2026cites this paper
• The Effect of Semaglutide on Pancreatic β-Cell Function in Adults with Type 2 Diabetes: A Systematic Review and Meta-Analysis

  2025cites this paper
• Biochemical, histological, and immunohistochemical study on the therapeutic effects and mechanism of coenzyme Q10 in type 2 diabetes mellitus

  2025cites this paper
• LDHA induces beta cell dedifferentiation in diabetes through metabolic and epigenetic reprogramming

  2025cites this paper
• Clinical Outcomes and Complications of Basal, Bolus, and Combination Insulin Regimens in Type 2 Diabetes Mellitus: Evidence from Published Case Reports

  2025cites this paper
• A dissociated glucocorticoid receptor modulator mitigates glucolipotoxicity in the endocrine pancreas and peripheral tissues: Preclinical data from a mouse model of diet-induced type 2 diabetes.

  2025cites this paper
• Nutritional ketosis as therapeutic regimen for metabolic disorders: Perspectives and challenges

  2025cites this paper
• Efficacy and safety of iGlarLixi versus IDegAsp by baseline β‐cell function in Chinese people with type 2 diabetes: Exploratory analyses of the Soli‐D study

  2025cites this paper
• Inflammatory Signaling Pathways in Pancreatic β-cell: New Insights into Type 2 Diabetes Pathogenesis.

  2025cites this paper
• Does Zn-Mediated Regulation of the Kynurenine Pathway Provide the Link Between Periodontal Disease and Diabetes?

  2025cites this paper
• Targeting the root cause of obesity-related comorbidities through weight independent and dependent actions on insulin sensitivity: Benefits of dual amylin and calcitonin receptor agonists.

  2025cites this paper
• Association of soluble apoptotic biomarkers (FAS,TNFR1 and TRAIL-R2) with β-cell dysfunction in early glucose dysregulation

  2025influential citation
• Promoting Secretion of Pathological Tau Species Using an Induced Proximity Platform That Engages the Autophagy Pathway.

  2025cites this paper
• POTENSI HIDROLISAT PROTEIN IKAN DALAM KONTROL GLUKOSA DARAH DAN NAFSU MAKAN PADA OBESITAS UNTUK MENCEGAH DIABETES MELITUS TIPE 2: LITERATURE REVIEW

  2025cites this paper
• Impact of diabetes on cellular connections: Pathological insights and emerging therapeutic targets.

  2025cites this paper
• Synergism of Synthetic Sulfonamides and Natural Antioxidants for the Management of Diabetes Mellitus Associated with Oxidative Stress

  2025cites this paper
• Psyllium-derived, medium-molecular weight arabinoxylan enables modulation of the gut microbiota and metabolites in type 2 diabetic mice.

  2025cites this paper
• Overcoming Curcumin's Limitations: Synthetic Derivatives in Diabetes and Cancer Management

  2025cites this paper
• Non-Linear Relationship Between Fasting C-Peptide and Retinopathy in Patients with Type 2 Diabetes Mellitus - A Retrospective Study

  2025cites this paper
• Effectiveness of SGLT2 inhibitors compared to sulfonylureas for long-term glycemic control in type 2 diabetes: A meta-analysis

  2025cites this paper
• GLP-1R in diabetes mellitus: from basic discovery to therapeutics development

  2025cites this paper
• New-Onset Type 1 Diabetes in a Child with Joubert Syndrome: A Rare Endocrine Complication

  2025cites this paper
• New approach to optimize therapy in type 2 diabetes mellitus: the importance of subclassification

  2025cites this paper
• Impact of 3 G rice on plasma glucose, insulin, and gastrointestinal hormones in patients with obesity or type 2 diabetes: A non-randomized experimental study.

  2025cites this paper
• Pancreatic β‐cell turnover in health and disease

  2025cites this paper
• Ranolazine: An Established Anti-Anginal Drug with Emerging Antidiabetic Potential Supported by Preclinical and Clinical Evidence.

  2025cites this paper
• Retrospective Evaluation of the Impact of a Multidisciplinary One-Year Online Lifestyle Intervention on Type 2 Diabetes Remission in Nonobese Indian Patients

  2025cites this paper
• Exosomes in aging and age-related disorders: mechanisms, therapeutic potentials, and challenges

  2025cites this paper
• Time Restricted Eating Improves Intermittent Hypoxia-Induced Dysglycemia.

  2025cites this paper
• Consideration of sex as a biological variable in diabetes research across twenty years

  2024cites this paper
• Real-world effectiveness of imeglimin in patients with type 2 diabetes: A retrospective longitudinal study in Japan.

  2024cites this paper
• EFEKTIVITAS SEDUHAN DAUN ASAM JAWA TERHADAP KADAR HOMA-IR DAN HOMA-β PADA PASIEN DIABETES MELLITUS TIPE 2

  2024cites this paper
• REDOX SIGNALLING IN THE PANCREAS IN HEALTH AND DISEASE.

  2024cites this paper
• Metabolic stress levels influence the ability of the myelin transcription factors to regulate β-cell identity and survival.

  2024cites this paper
• DISSECT: deep semi-supervised consistency regularization for accurate cell type fraction and gene expression estimation

  2024cites this paper
• Biomarkers of insulin sensitivity/resistance

  2024cites this paper
• Remission of type 2 diabetes mellitus

  2024cites this paper
• Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6)

  2024cites this paper
• Using Pre-operative Insulin Dose to Predict Diabetes Remission After Roux-En-Y Gastric Bypass and Sleeve Gastrectomy

  2024cites this paper
• Analyzing pancreatic characteristics in diabetic patients: A texture-based CT investigation with volume assessment

  2024cites this paper
• Diabetes and its Silent Partner: A Critical Review of Hyperinsulinemia and its Complications.

  2024cites this paper
• The Roles of Glutathione and Oxidative Stress in Diabetes and COVID-19

  2024cites this paper
• Macular pigments produced from microalga Chlorella sp. and applied to alleviate the pathogenic process in diabetic mice

  2024cites this paper
• A Review of Antidiabetic Medicinal Plants as a Novel Source of Phosphodiesterase Inhibitors: Future Perspective of New Challenges Against Diabetes Mellitus.

  2024cites this paper
• A novel simple disposition index (SPINA‐DI) from fasting insulin and glucose concentration as a robust measure of carbohydrate homeostasis

  2024cites this paper
• The clinical relevance of a polygenic risk score for type 2 diabetes mellitus in the Korean population

  2024cites this paper
• Performance of the 1 h oral glucose tolerance test in predicting type 2 diabetes and association with impaired β-cell function in Asians: a national prospective cohort study

  2024cites this paper
• MetAP2 as a Therapeutic Target for Obesity and Type 2 Diabetes: Structural Insights, Mechanistic Roles, and Inhibitor Development

  2024cites this paper
• Non‐lethal sonodynamic therapy inhibits high glucose and palmitate‐induced macrophage inflammasome activation through mtROS‐DRP1‐mitophagy pathway

  2024cites this paper
• The Emerging Role of p21 in Diabetes and Related Metabolic Disorders

  2024cites this paper
• Reply - "Letter to the Editor-Very-low calorie diet and Semaglutide: Synergy and long-term impact on type 2 diabetes management".

  2024cites this paper
• Insulin resistance and secretion change after 3 years follow-up and the risk for developing diabetes in non-diabetic adults

  2024cites this paper
• CD36 gene variant rs1761667(G/A) as a biomarker in obese type 2 diabetes mellitus cases

  2024cites this paper
• Unlocking the potential of glucagon-like peptide-1 receptor agonists in revolutionizing type 2 diabetes management: a comprehensive review

  2024cites this paper
• High incidence of low interstitial fluid glucose among type 2 diabetes patients with chronic kidney disease (CKD) despite adhering to appropriate glycated haemoglobin targets—has time come for robust integration of interstitial fluid glucose targets into glycaemic guidelines?

  2024cites this paper
• Glucose-lowering effect of Reducose® enriched with 1-deoxynojirimycin and l-leucine: Studies on insulin secretion in INS-1 cells and reduction of blood glucose in diabetic rats

  2024cites this paper
• Comparative transcriptomic analysis reveals the underlying molecular mechanism in high-fat diet-induced islet dysfunction

  2023cites this paper
• Initiating or switching to IDegAsp in a real-world South African population with type 2 diabetes – a cohort analysis from the ARISE study

  2023cites this paper
• Hidden chronic metabolic acidosis of diabetes type 2 (CMAD): Clues, causes and consequences

  2023cites this paper
• Age at diagnosis modifies associations of type 2 diabetes with cancer incidence and mortality: a retrospective matched-cohort study

  2023cites this paper
• Chemical Constituents from the Roots of Angelica reflexa That Improve Glucose-Stimulated Insulin Secretion by Regulating Pancreatic β-Cell Metabolism

  2023cites this paper
• Albumin-binding DARPins as scaffold improve the hypoglycemic and anti-obesity effects of exendin-4 in vivo.

  2023cites this paper
• Protein glycation in diabetes mellitus.

  2023cites this paper
• A Novel Algorithm for the Management of Inpatient COVID-19 Glucocorticoid-Induced Hyperglycemia.

  2023cites this paper
• The Efficacy and Safety of Astragalus as an Adjuvant Treatment for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

  2023cites this paper
• A Single-Point Insulin Sensitivity Estimator (SPISE) of 5.4 is a good predictor of both metabolic syndrome and insulin resistance in adolescents with obesity

  2023cites this paper
• The Potential Role of Gossypetin in the Treatment of Diabetes Mellitus and Its Associated Complications: A Review

  2023cites this paper
• The Role of Lifestyle Interventions in the Prevention and Treatment of Gestational Diabetes Mellitus

  2023cites this paper
• Transplantation of adipose derived stem cells in diabetes mellitus; limitations and achievements

  2023cites this paper
• A data integration approach unveils a transcriptional signature of type 2 diabetes progression in rat and human islets

  2023cites this paper
• Association Between Serum Glycated Hemoglobin Levels at Early Gestation and the Risk of Subsequent Pregnancy Loss in Pregnant Women Without Diabetes Mellitus: Prospective Cohort Study

  2023cites this paper
• Prevalensi dan faktor risiko penyakit jantung koroner pada pasien diabetes melitus tipe 2 Rumah Sakit Umum Pusat Prof. Dr. I.G.N.G. Ngoerah Denpasar

  2023cites this paper
• Reinstating acute-phase insulin release among sedentary adults at high risk for type 2 diabetes with Yoga and Walking based lifestyle modification.

  2023cites this paper
• Beta‐cell function in treatment‐naïve patients with type 2 diabetes mellitus: Analyses of baseline data from 15 clinical trials

  2023cites this paper
• Automated High-Throughput, High-Content 3D Imaging of Intact Pancreatic Islets.

  2023cites this paper
• Effect of a 12-Week Polyphenol Rutin Intervention on Markers of Pancreatic β-Cell Function and Gut Microbiota in Adults with Overweight without Diabetes

  2023cites this paper
• E ff ect of a 12 ‐ Week Polyphenol Rutin Intervention on Markers of Pancreatic β‐ Cell Function and Gut Microbiota in Adults with Overweight without Diabetes

  2023cites this paper
• Modulation of transcription factors by small molecules in β-cell development and differentiation.

  2023cites this paper
• Cut&tag: a powerful epigenetic tool for chromatin profiling

  2023cites this paper
• Sex differences in islet stress responses support female β cell resilience

  2023cites this paper
• Impact of butylparaben on β‐cell damage and insulin/PEPCK expression in zebrafish larvae: Protective effects of morin

  2023cites this paper
• Algerian Capparis spinosa n-BuOH Extract Alleviates Diabetic Neuropathy Induced with Streptozotocin in Ratss

  2022cites this paper
• Role of Polyamines and Hypusine in β Cells and Diabetes Pathogenesis

  2022cites this paper
• Association between distinct body mass index trajectories according to the group‐based trajectory modeling and the risk of incident diabetes: A systematic review

  2022cites this paper
• Dietary protein and the glycemic index handle insulin resistance within a nutritional program for avoiding weight regain after energy-restricted induced weight loss

  2022cites this paper
• An environmentally sensitive molecular rotor as a NIR fluorescent probe for the detection of islet amyloid polypeptide.

  2022cites this paper
• Human islet amyloid polypeptide: A therapeutic target for the management of type 2 diabetes mellitus

  2022cites this paper
• Sex differences in islet stress responses support female beta cell resilience

  2022cites this paper
• White saffron (Curcuma mangga Val.) attenuates diabetes and improves pancreatic β-cell regeneration in streptozotocin-induced diabetic rats

  2022cites this paper
• Bariatric surgery for the management of type 2 diabetes mellitus-current trends and challenges: a review article.

  2022cites this paper
• Radiomics-based machine learning (ML) classifier for detection of type 2 diabetes on standard-of-care abdomen CTs: a proof-of-concept study

  2022cites this paper
• The dual role of empagliflozin: Cardio renal protection in T2DM patients

  2022cites this paper